Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07091968 · ClinicalTrials.gov registry record · NA

Feasibility of a Technology-Based Intervention for Depression Referral Uptake in Cancer Survivors

A NA study of Depression and Cancer, sponsored by Medical University of South Carolina.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT07091968 is a NA study of Depression and Cancer that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 60 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07091968, a NA study of Depression and Cancer, is actively recruiting participants, sponsored by Medical University of South Carolina.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

Depression is very common in cancer survivors but there are challenges to linking those in need of treatment efficiently to care. In this study, investigators will test the feasibility and acceptability of a new text-based approach to connect cancer survivors with depression with care.

Conditions Studied

Interventions

  • BEHAVIORAL Technology-Enabled Tailored Referral

Study Locations (1)

South Carolina

  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2026-01-16
Est. Completion 2026-12
Phase NA

What the Registry Record Tells You About NCT07091968

The ClinicalTrials.gov registry entry for NCT07091968 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (92% lower). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Technology-Enabled Tailored Referral is the first listed.

NCT07091968 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.

Frequently Asked Questions

What is clinical trial NCT07091968 about?

NCT07091968 is a clinical study titled "Feasibility of a Technology-Based Intervention for Depression Referral Uptake in Cancer Survivors". Depression is very common in cancer survivors but there are challenges to linking those in need of treatment efficiently to care. In this study, investigators will test the feasibility and acceptability of a new text-based approach to connect cancer survivors with depression with care.

What is the current status of trial NCT07091968?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-01-16. Estimated completion is 2026-12.

What conditions does trial NCT07091968 study?

This clinical trial studies the following conditions: Depression, Cancer.

What interventions are being tested in trial NCT07091968?

The interventions under investigation include: Technology-Enabled Tailored Referral (BEHAVIORAL).

Who is sponsoring clinical trial NCT07091968?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07091968 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.